Improving neurological outcome after
spinal cord injury is a major clinical challenge because axons, once severed, do not regenerate but 'dieback' from the lesion site. Although microglia, the immunocompetent cells of the brain and spinal cord respond rapidly to
spinal cord injury, their role in
subsequent injury or repair remains unclear. To assess the role of microglia in spinal cord white matter injury we used time-lapse two-photon and spectral confocal imaging of
green fluorescent protein-labelled microglia, yellow fluorescent
protein-labelled axons, and
Nile Red-labelled myelin of living murine spinal cord and revealed dynamic changes in white matter elements after
laser-induced
spinal cord injury in real time. Importantly, our model of acute axonal injury closely mimics the axonopathy described in well-characterized clinically relevant models of
spinal cord injury including contusive-, compressive- and transection-based models. Time-lapse recordings revealed that microglia were associated with some acute pathophysiological changes in axons and myelin acutely after
laser-induced
spinal cord injury. These pathophysiological changes included myelin and axonal spheroid formation, spectral shifts in
Nile Red emission spectra in axonal endbulbs detected with spectral microscopy, and 'bystander' degeneration of axons that survived the initial injury, but then succumbed to secondary degeneration. Surprisingly, modulation of microglial-mediated release of neurotoxic molecules failed to protect axons and myelin. In contrast, sterile stimulation of microglia with the specific
toll-like receptor 2 agonist
Pam2CSK4 robustly increased the microglial response to ablation, reduced secondary degeneration of central myelinated fibres, and induced an alternative (mixed M1:M2) microglial activation profile. Conversely, Tlr2 knock out: Thy1 yellow fluorescent
protein double transgenic mice experienced greater axonal dieback than littermate controls. Thus, promoting an alternative microglial response through
Pam2CSK4 treatment is neuroprotective acutely following
laser-induced
spinal cord injury. Therefore, anti-inflammatory treatments that target microglial activation may be counterintuitive after
spinal cord injury.